Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
May
14
2021
Introduction of a Patent Box K&L Gates
Jul
15
2018
In the Weeds: Navigating the Shifting Federal Regulation of Medical Marijuana K&L Gates
Oct
20
2021
US Regulatory Considerations Applicable to Digital Health Providers and Suppliers - Part III: FDCA K&L Gates
Oct
28
2021
What Health Care Providers Should Expect in an FDA Inspection [PODCAST] K&L Gates
Jan
18
2022
COVID-19 Vaccination Sweepstakes: Best Practices for Employee Incentives K&L Gates
Apr
1
2020
Court Of Chancery Orders Specific Performance Of Merger Agreement, Finding That Fraud Contained In FDA Filings For Approval Of Target Product Did Not Rise To A “Material Adverse Effect” K&L Gates
Jan
18
2017
340B Update: HRSA Finalizes 340B Pricing & Penalties for Drug Manufacturers K&L Gates
Mar
23
2021
First Cannabis-Related Business SARS Penalty Against a Depository Institution K&L Gates
Jul
7
2021
340B Update: Delaware Court Denies 340B Program Statute Requiring Contract Pharmacy Arrangements K&L Gates
May
2
2022
Litigation Minute: Defending Consumer Class Action Claims Involving PFAS K&L Gates
Jul
15
2022
New FDA Draft Guidance Aiming to Prevent Drug Shortages Will Affect Pharmaceutical Manufacturers K&L Gates
Jul
15
2019
Beauty And The Beast – A Tale Of (Trade Mark Infringement) As Old As Time K&L Gates
Jun
4
2023
Highlights for Research Institutions and Sponsors in FDA's Recent Draft Guidance on Decentralized Clinical Trials K&L Gates
Aug
15
2023
Tea Parties Certified For Class Action K&L Gates
Apr
23
2020
COVID-19: IP Strategies for Universities and Nonprofits During the Pandemic – Mitigating Patent Infringement Risks When Making PPE and Other Health-Related Supplies K&L Gates
May
1
2020
COVID-19: Labs Beware! – EKRA Expands DOJ’s Enforcement Arsenal in the COVID-19 Fraud Battle K&L Gates
Jun
26
2020
Market Entry and Real World Data – China’s Medical Device Industry K&L Gates
Dec
2
2020
OIG Finalizes Rebate Rules: Removal of Safe Harbor Protections for Rebates and Creation of New Safe Harbors for Other Discounts and Service Fees K&L Gates
Dec
29
2020
Federal Courts Block Implementation of Most Favored Nation Drug Pricing Rule K&L Gates
Apr
20
2021
Cannabis Banking: The Safe Banking Act 2.0 Passes the House of Representatives K&L Gates
Jun
21
2018
Chocolate Slab-Gate K&L Gates
Jul
21
2021
Five Things to Know About the Changes to China's Medical Device Regulation K&L Gates
Aug
10
2021
CMS Proposes to Rescind Most Favored Nation Drug Pricing Rule K&L Gates
Nov
19
2021
COVID-19: Florida Curtails Vaccination Mandates for Private Employers K&L Gates
Jun
21
2022
Supreme Court Issues Decision Favorable to Hospitals on 340 B Payment Reduction: What to Do Next K&L Gates
Jul
26
2022
Litigation Minute: Red Lobster Complaint Highlights Threat of ESG Litigation to The Food and Beverage Industry K&L Gates
Jul
29
2019
The Scotch Whisky Saga: Where Name And Reputation Is Not Enough K&L Gates
Mar
23
2017
Medicinal Products: the EU and the US Mutually Recognize Manufacturing Standards K&L Gates
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins